Disclosure Information

It is the policy of the University of Nebraska Medical Center, Center for Continuing Education and Letters & Sciences to ensure balance, independence, objectivity, and scientific rigor in all their sponsored educational activities.  All faculty participating in this activity are expected to disclose to the audience any real or perceived conflicts of interest related to the content of their presentations.

It is not assumed that these financial interests or affiliations will have an adverse impact on the faculty presentations.  They simply are noted here to fully inform course participants.

George D. Demetri, MD

Consultant: Novartis Pharmaceuticals

Chandrajit P. Raut, MD, MSc

Honorarium:  Novartis Pharmaceuticals
 

Brian Rubin, MD, PhD

Consultant: Novartis Pharmaceuticals

Unlabeled Uses/Investigational Uses/Not Yet Approved Commercial Products

Participants are advised that some sections in this educational activity may contain references to unlabeled or unapproved uses of drugs or therapeutic strategies. Not all agents and/or protocols described in the presentations may be approved by the FDA. Physicians should note that the use of these agents and/or protocols outside their current approved labeling is considered experimental and are advised to consult the current prescribing information for these products. The faculty is required to disclose their discussion of drugs, medical devices, or therapeutic strategies that are unlabeled, investigational, or not approved for the use that is being discussed.

George D. Demetri, MD

Will be discussing off-label use of KIT inhibitors and other targeted agents for 3^rd line therapy

Chandrajit P. Raut, MD, MSc

Will be discussing off-label use of TKIs in the neoadjuvant setting

Brian P. Rubin, MD, PhD

Will be discussing off-label use of KIT inhibitors and other targeted agents for 3rd-line therapy

External Review

In accordance with the policies of the University of Nebraska Medical Center, Center for Continuing Education and Letters & Sciences, and in compliance with the standards of ACCME and ANCC to identify and resolve any potential conflicts of interest, to assure fair balance, independence and objectivity, and to instill scientific rigor in all CME/CNE activities, all presentations with any potential for conflict of interest, have been reviewed by external reviewers. The external reviewers, who have no potential conflicts of interest, have determined that no bias exists in these presentations. The external reviewers are:

Allen Yudovich, MD

Department of Gastroenterology
Henry Ford Hospital System
Detroit, MI

Michelle Nichols, PharmD

Pharmacy Consultant, Private Practice
Raritan, NJ